These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16572409

  • 1. Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data.
    Lamerato L, Havstad S, Gandhi S, Jones D, Nathanson D.
    Cancer; 2006 May 01; 106(9):1875-82. PubMed ID: 16572409
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM, Shim B, Goodman S, Amonkar MM.
    Breast Cancer Res Treat; 2008 Mar 01; 108(2):297-305. PubMed ID: 17577662
    [Abstract] [Full Text] [Related]

  • 3. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
    Groot MT, Baltussen R, Uyl-de Groot CA, Anderson BO, Hortobágyi GN.
    Breast J; 2006 Mar 01; 12 Suppl 1():S81-90. PubMed ID: 16430401
    [Abstract] [Full Text] [Related]

  • 4. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH.
    Lung Cancer; 2005 Nov 01; 50(2):143-54. PubMed ID: 16112249
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE, Karnon J, Smith RE, Johnston SR, Brandman J, Sung JC, Gross PE.
    Am J Manag Care; 2006 Jul 01; 12(7):374-86. PubMed ID: 16834524
    [Abstract] [Full Text] [Related]

  • 6. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR.
    Cancer; 2007 Feb 01; 109(3):518-27. PubMed ID: 17186528
    [Abstract] [Full Text] [Related]

  • 7. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
    Sasser AC, Rousculp MD, Birnbaum HG, Oster EF, Lufkin E, Mallet D.
    Womens Health Issues; 2005 Feb 01; 15(3):97-108. PubMed ID: 15894195
    [Abstract] [Full Text] [Related]

  • 8. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.
    Oestreicher N, Ramsey SD, McCune JS, Linden HM, Veenstra DL.
    Cancer; 2005 Nov 15; 104(10):2054-62. PubMed ID: 16216002
    [Abstract] [Full Text] [Related]

  • 9. [Advanced breast cancer: an evaluation of the cost of recurrence].
    Bercez C, Lebrun T, Bonneterre ME, Selke B, Lenne X, Bonneterre J.
    Bull Cancer; 1999 Jun 15; 86(6):585-90. PubMed ID: 10417432
    [Abstract] [Full Text] [Related]

  • 10. Use of the levonorgestrel-releasing intrauterine system in breast cancer patients.
    Trinh XB, Tjalma WA, Makar AP, Buytaert G, Weyler J, van Dam PA.
    Fertil Steril; 2008 Jul 15; 90(1):17-22. PubMed ID: 17706209
    [Abstract] [Full Text] [Related]

  • 11. Clinical model of lifetime cost of treating bladder cancer and associated complications.
    Avritscher EB, Cooksley CD, Grossman HB, Sabichi AL, Hamblin L, Dinney CP, Elting LS.
    Urology; 2006 Sep 15; 68(3):549-53. PubMed ID: 16979735
    [Abstract] [Full Text] [Related]

  • 12. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D, Rawlinson E, Narod SA, Sun P, Lickley HL, McCready DR, Holloway CM.
    Breast J; 2006 Sep 15; 12(4):331-7. PubMed ID: 16848842
    [Abstract] [Full Text] [Related]

  • 13. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, Ellard S, Norris B, Hayes M, Barnett J, Gelmon KA.
    Cancer; 2008 Apr 01; 112(7):1437-44. PubMed ID: 18286526
    [Abstract] [Full Text] [Related]

  • 14. Resource utilization for ovarian cancer patients at the end of life: how much is too much?
    Lewin SN, Buttin BM, Powell MA, Gibb RK, Rader JS, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2005 Nov 01; 99(2):261-6. PubMed ID: 16140364
    [Abstract] [Full Text] [Related]

  • 15. Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer.
    Indelicato D, Grobmyer SR, Newlin H, Morris CG, Haigh LS, Copeland EM, Mendenhall NP.
    Surgery; 2007 May 01; 141(5):645-53. PubMed ID: 17462465
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M, MacGrogan G, Brouste V, Mathoulin-Pelissier S, Durand M, Mauriac L.
    Cancer; 2007 Jun 01; 109(11):2197-204. PubMed ID: 17450590
    [Abstract] [Full Text] [Related]

  • 17. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
    Mansell J, Monypenny IJ, Skene AI, Abram P, Carpenter R, Gattuso JM, Wilson CR, Angerson WJ, Doughty JC.
    Breast Cancer Res Treat; 2009 Sep 01; 117(1):91-8. PubMed ID: 19112615
    [Abstract] [Full Text] [Related]

  • 18. Assessing the economic burden of breast cancer in a US managed care population.
    Barron JJ, Quimbo R, Nikam PT, Amonkar MM.
    Breast Cancer Res Treat; 2008 May 01; 109(2):367-77. PubMed ID: 17674201
    [Abstract] [Full Text] [Related]

  • 19. The economic burden of breast cancer in California.
    Max W, Sung HY, Stark B.
    Breast Cancer Res Treat; 2009 Jul 01; 116(1):201-7. PubMed ID: 18683041
    [Abstract] [Full Text] [Related]

  • 20. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S, Masuda Y, Kurizaki T, Haga Y, Murayama T, Ikei S, Kamei M, Takeno S, Kawahara K.
    Anticancer Res; 2007 Jul 01; 27(4C):2803-8. PubMed ID: 17695451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.